Novel mutations of the MET proto-oncogene in papillary renal carcinomas

Overview of attention for article published in Oncogene, April 1999

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

policy: 1 policy source
patent: 101 patents

guideline: 1 clinical guideline source

Readers on

mendeley: 99 Mendeley

So far, Altmetric has seen 101 patents that reference this research output.

Amorphous kinase inhibitor formulations and methods of use thereof

Grant US-12708617-B2

United States of America

18 Aug 2026

Methods for treating vascular malformations

Grant US-12691108-B2

United States of America

28 Jul 2026

Combination therapy for the treatment of gastrointestinal stromal tumors

Grant US-12616683-B2

United States of America

05 May 2026

CD71 binding fibronectin type III domains

Grant US-12589159-B2

United States of America

31 Mar 2026

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 97 additional patents.